LncRNA polymorphisms and upper gastrointestinal cancer risk

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Upper gastrointestinal (GI) cancers, including oral, esophageal, and gastric cancers, present a significant health challenge due to high mortality rates and late-stage diagnosis.
• Early clinical symptoms are often absent, necessitating a deeper understanding of the molecular mechanisms driving cancer origin and progression.

Purpose of the Study:

• To evaluate the mechanisms underlying upper GI cancer development.
• To identify novel therapeutic targets and effective strategies for controlling GI cancers.
• To summarize lncRNA-related polymorphisms and their role in upper GI cancer development.

Main Methods:

• Genome-wide approaches to identify long non-coding RNAs (lncRNAs) in malignant and normal tissues.
• Analysis of lncRNA-associated single nucleotide polymorphisms (SNPs) and their impact on gene regulation and signaling pathways.
• Review and summarization of existing data on genetic variations in lncRNAs relevant to upper GI cancers.

Main Results:

• Aberrant expression of specific lncRNAs is linked to the diagnosis and prognosis of upper GI cancer patients.
• lncRNA-associated SNPs can interfere with lncRNA function, affecting key signaling pathways and carcinogenesis.
• Genetic variations in lncRNAs, particularly polymorphisms, influence gene expression levels and lncRNA functionalities.

Conclusions:

• lncRNA-related polymorphisms play a significant role in the development of upper GI cancers.
• Individual and combined genotypes of lncRNA-related polymorphisms may serve as predictive markers for cancer risk.
• These genetic markers could potentially predict clinical and therapeutic outcomes in upper GI cancer patients.